نصائح البحث
sorted by
30 shown of 390 entities
7 columns hidden
Title | Date added | Template | Original document | Paragraph text | Body | Document type | Thematics | Topic(s) | Person(s) affected | Year |
---|---|---|---|---|---|---|---|---|---|---|
–2010: Decade to Roll Back Malaria in Developing Countries, Particularly in Africa (2003), para. 22 | Feb 25, 2020 | Paragraph | (a) At least 60 per cent of those at risk for malaria, in particular pregnant women and children under five years of age, benefit from the most suitable combination of personal and community protective measures, such as insecticide- treated bednets and other interventions that are accessible and affordable, to prevent infection and suffering; |
|
| |||||
–2010: Decade to Roll Back Malaria in Developing Countries, Particularly in Africa (2003), para. 23 | Feb 25, 2020 | Paragraph | (b) At least 60 per cent of all pregnant women who are at risk for malaria, especially those in their first pregnancy, have access to chemoprophylaxis or presumptive intermittent treatment; |
|
| |||||
–2010: Decade to Roll Back Malaria in Developing Countries, Particularly in Africa (2006), para. 26 | Feb 25, 2020 | Paragraph | 14. Calls upon the international community to support investment in the development of new medicines to prevent and treat malaria, especially for children and pregnant women, sensitive and specific diagnostic tests, effective vaccines, and new insecticides and delivery modes in order to enhance effectiveness and delay the onset of resistance, including through existing partnerships; |
|
| |||||
–2010: Decade to Roll Back Malaria in Developing Countries, Particularly in Africa (2007), para. 27 | Feb 25, 2020 | Paragraph | 15. Calls upon the international community, including through existing partnerships, to increase investment in and efforts towards the research and development of new, safe and affordable malaria-related medicines, products and technologies, such as vaccines, rapid diagnostic tests, insecticides and delivery modes, to prevent and treat malaria, especially for at-risk children and pregnant women, in order to enhance effectiveness and delay the onset of resistance; |
|
| |||||
–2010: Decade to Roll Back Malaria in Developing Countries, Particularly in Africa (2007), para. 34 | Feb 25, 2020 | Paragraph | 22. Urges the international community to become fully knowledgeable about World Health Organization technical policies and strategies, including for indoor residual spraying, insecticide-treated nets and case management, intermittent preventive treatment for pregnant women and monitoring of in vivo resistance studies to artemisinin-based combination therapy treatment, so that projects support those policies and strategies; |
|
| |||||
–2010: Decade to Roll Back Malaria in Developing Countries, Particularly in Africa (2008), para. 28 | Feb 25, 2020 | Paragraph | 16. Calls upon the international community, including through existing partnerships, to increase investment in and efforts towards the research and development of new, safe and affordable malaria-related medicines, products and technologies, such as vaccines, rapid diagnostic tests, insecticides and delivery modes, to prevent and treat malaria, especially for at-risk children and pregnant women, in order to enhance effectiveness and delay the onset of resistance; |
|
| |||||
–2010: Decade to Roll Back Malaria in Developing Countries, Particularly in Africa (2010), para. 30 | Feb 25, 2020 | Paragraph | 15. Requests relevant international organizations, in particular the World Health Organization and the United Nations Children’s Fund, to assist efforts of national Governments to provide universal access to malaria control interventions especially to address at-risk young children and pregnant women in malaria-endemic countries, particularly in Africa, as rapidly as possible, with due regard to ensuring proper use of those interventions, including long-lasting insecticide nets, and sustainability through full community participation and implementation through the health system; |
|
| |||||
–2010: Decade to Roll Back Malaria in Developing Countries, Particularly in Africa (2010), para. 37 | Feb 25, 2020 | Paragraph | 22. Calls upon the international community, including through existing partnerships, to increase investment in and efforts towards the research and development of new, safe and affordable malaria-related medicines, products and technologies, such as vaccines, rapid diagnostic tests, insecticides and delivery modes, to prevent and treat malaria, especially for at-risk children and pregnant women, in order to enhance effectiveness and delay the onset of resistance; |
|
| |||||
–2010: Decade to Roll Back Malaria in DevelopingCountries, Particularly in Africa (2001), para. 16 | Feb 25, 2020 | Paragraph | (a) At least 60 per cent of those at risk for malaria, particularly pregnant women and children under five years of age, shall benefit from the most suitable combination of personal and community protective measures, such as insecticide- treated bednets and other interventions that are accessible and affordable, to prevent infection and suffering; |
|
| |||||
–2010: Decade to Roll Back Malaria in DevelopingCountries, Particularly in Africa (2001), para. 17 | Feb 25, 2020 | Paragraph | (b) At least 60 per cent of all pregnant women who are at risk for malaria, especially those in their first pregnancies, shall have access to chemoprophylaxis or presumptive intermittent treatment; |
|
| |||||
Access to medication in the context of pandemics such as HIV/AIDS, tuberculosis and malaria (2004), para. 42 | Feb 25, 2020 | Paragraph | 13. Calls upon States to ensure that those at risk of contracting malaria, in particular pregnant women and children under five years of age, benefit from the most suitable combination of personal and community protective measures, such as insecticide treated bed nets and other interventions that are accessible and affordable, in order to prevent infection and suffering; |
|
| |||||
Access to medicines and vaccines in the context of the right of everyone to the enjoyment of the highest attainable standard of physical andmental health (2019), para. 07 | Feb 25, 2020 | Paragraph | Welcoming the Sustainable Development Goals, including, inter alia, Goal 3 on ensuring healthy lives and promoting well-being for all at all ages, as well as its specific and interlinked targets, such as target 3.8 on achieving universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all, other health- related Goals and targets, and the guiding principle of the 2030 Agenda, to leave no one behind, |
|
| |||||
Access to medicines and vaccines in the context of the right of everyone to the enjoyment of the highest attainable standard of physical andmental health (2019), para. 10 | Feb 25, 2020 | Paragraph | Recalling General Assembly resolution 71/3 of 5 October 2016, in which the Assembly adopted the political declaration of the high-level meeting of the General Assembly on antimicrobial resistance, wherein Heads of State and Government and other representatives underlined that affordability and access to existing and new antimicrobial medicines, vaccines and diagnostics should be a global priority and should take into account the needs of all countries, |
|
| |||||
Access to medicines and vaccines in the context of the right of everyone to the enjoyment of the highest attainable standard of physical andmental health (2019), para. 14 | Feb 25, 2020 | Paragraph | Welcoming the WHO Road Map for Access to Medicines, Vaccines and other Related Health Products 2019–2023 presented at the seventy-second session of the World Health Assembly, which recognizes that improving access to health products is a multidimensional challenge that requires comprehensive national policies and strategies aligning public health needs with economic and social development objectives, and promoting collaboration with other sectors, partners and stakeholders, |
|
| |||||
Access to medicines and vaccines in the context of the right of everyone to the enjoyment of the highest attainable standard of physical andmental health (2019), para. 15 | Feb 25, 2020 | Paragraph | Reaffirming the importance of improving the transparency of markets for medicines, vaccines and other health products across the whole value chain, and taking into consideration resolution WHA72.8 adopted by the World Health Assembly at its seventy- second session, |
|
| |||||
Access to medicines and vaccines in the context of the right of everyone to the enjoyment of the highest attainable standard of physical andmental health (2019), para. 20 | Feb 25, 2020 | Paragraph | Recognizing that universal health coverage implies that all people have access without discrimination to nationally determined sets of needed promotive, preventive, curative, palliative and rehabilitative essential health-care services, and essential, safe, affordable, effective and quality medicines and vaccines, while ensuring that the use of these services does not expose users to financial hardship, with special emphasis on the poor, vulnerable and marginalized segments of the population, |
|
| |||||
Access to medicines and vaccines in the context of the right of everyone to the enjoyment of the highest attainable standard of physical andmental health (2019), para. 33 | Feb 25, 2020 | Paragraph | 2. Stresses the responsibility of States to ensure access for all, without discrimination, to medicines and vaccines, in particular essential medicines, that are affordable, safe, effective and of quality; |
| ||||||
Access to medicines and vaccines in the context of the right of everyone to the enjoyment of the highest attainable standard of physical andmental health (2019), para. 34 | Feb 25, 2020 | Paragraph | 3. Calls upon States to promote access to safe, effective, quality and affordable medicines and vaccines for all, including through the use to the full of the provisions of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement), which provide flexibility for that purpose, while recognizing that the protection of intellectual property is important for the development of new and innovative medicines and vaccines, and the concerns about its effects on prices and public health; |
|
| |||||
Access to medicines and vaccines in the context of the right of everyone to the enjoyment of the highest attainable standard of physical andmental health (2019), para. 35 | Feb 25, 2020 | Paragraph | 4. Also calls upon States to take steps to implement policies and plans to promote access to comprehensive and cost-effective prevention, treatment and care for the integrated management of non-communicable diseases, including, inter alia, increased access to affordable, safe, effective and quality medicines, vaccines and diagnostics and other health products, including through the full use of TRIPS Agreement provisions and flexibilities; |
|
| |||||
Access to medicines and vaccines in the context of the right of everyone to the enjoyment of the highest attainable standard of physical andmental health (2019), para. 36 | Feb 25, 2020 | Paragraph | 5. Reiterates the call upon States to continue to collaborate, as appropriate, on models and approaches that support the delinkage of the cost of new research and development from the prices of medicines, vaccines and diagnostics for diseases that predominantly affect developing countries, including emerging and neglected tropical diseases, so as to ensure their sustained accessibility, affordability and availability and to ensure access to treatment for all those in need; |
|
| |||||
Access to medicines and vaccines in the context of the right of everyone to the enjoyment of the highest attainable standard of physical andmental health (2019), para. 38 | Feb 25, 2020 | Paragraph | 7. Recognizes the innovative funding mechanisms that contribute to the availability of vaccines and medicines in developing countries, such as the Global Fund to Fight AIDS, Tuberculosis and Malaria, the Gavi Alliance and UNITAID, and calls upon all States, United Nations agencies, funds and programmes, in particular the World Health Organization, and relevant intergovernmental organizations, within their respective mandates, and encourages relevant stakeholders, including companies involved in the research and development, manufacture, importing, distribution and supply of pharmaceuticals, while safeguarding public health from undue influence by any form of real, perceived or potential conflict of interest, to further collaborate to enable equitable access to quality, safe and effective medicines and vaccines that are affordable to all, including those living in poverty, children and other persons in vulnerable situations; |
|
| |||||
Access to medicines and vaccines in the context of the right of everyone to the enjoyment of the highest attainable standard of physical andmental health (2019), para. 43 | Feb 25, 2020 | Paragraph | 12. Invites the Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health, while considering the many ways towards the full realization of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health, to continue to focus on the human rights dimension of access to medicines and vaccines when discharging his or her duties, in accordance with the mandate; |
|
| |||||
Access to medicines and vaccines in the context of the right of everyone to the enjoyment of the highest attainable standard of physical andmental health (2019), para. 44 | Feb 25, 2020 | Paragraph | 13. Invites Member States and all stakeholders, including relevant United Nations bodies, agencies, funds and programmes, treaty bodies, special procedure mandate holders, national human rights institutions, civil society and the private sector, to promote policy coherence in the areas of human rights, public health, intellectual property and international trade and investment when considering access to medicines and vaccines; |
|
| |||||
Access to medicines and vaccines in the context of the right of everyone to the enjoyment of the highest attainable standard of physical andmental health (2019), para. 46 | Feb 25, 2020 | Paragraph | (a) To convene, before the forty-sixth session of the Human Rights Council, a full-day intersessional seminar on good practices, key challenges and new developments relevant to access to medicines and vaccines as one of the fundamental elements of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health, in coordination with the World Health Organization; |
|
| |||||
Access to medicines in the context of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health (2013), para. 36 | Feb 25, 2020 | Paragraph | 8. Recognizes the innovative funding mechanisms that contribute to the availability of vaccines and medicines in developing countries, such as the Global Fund to Fight AIDS, Tuberculosis and Malaria, the GAVI Alliance and the International Drug Purchase Facility, UNITAID, and calls upon all States, United Nations programmes and agencies, in particular the World Health Organization, and relevant intergovernmental organizations, within their respective mandates, and encourages relevant stakeholders, including pharmaceutical companies, while safeguarding public health from undue influence by any form of real, perceived or potential conflict of interest, to further collaborate to enable equitable access to quality, safe and efficacious medicines that are affordable to all, including those living in poverty, children and other persons in vulnerable situations; |
|
| |||||
Addressing the socioeconomic needs of individuals, families and societies affected by autism spectrum disorders, developmental disorders and associated disabilities (2013), para. 25 | Feb 25, 2020 | Paragraph | (c) Enhancing inclusive educational programmes suited to infants, children (d) Emphasizing the unique needs of each person with autism across a spectrum of different characteristics and experiences; |
|
| |||||
Birth registration and the right of everyone to recognition everywhere as a person before the law (2013), para. 07 | Feb 25, 2020 | Paragraph | Welcoming the continuing efforts of the Committee on the Rights of the Child towards universal birth registration, such as through recommendations widely addressed to States in this regard, |
|
| |||||
Birth registration and the right of everyone to recognition everywhere as a person before the law (2013), para. 08 | Feb 25, 2020 | Paragraph | Recalling the resolutions adopted by the General Assembly and the Human Rights Council calling upon States to ensure the registration of all children immediately after birth, the most recent being Assembly resolution 66/141 of 19 December 2011 and Council resolution 19/9 of 22 March 2012, |
|
| |||||
Birth registration and the right of everyone to recognition everywhere as a person before the law (2013), para. 09 | Feb 25, 2020 | Paragraph | Recognizing the importance of birth registration, including late birth registration and provision of documents of proof of birth, as a means for providing an official record of the existence of a person and the recognition of that individual as a person before the law; expressing concern that unregistered individuals have limited or no access to services and enjoyment of all the rights to which they are entitled; taking into consideration that persons without birth registration are vulnerable to lack of protection; and aware that registering a person’s birth is a vital step towards the promotion and protection of all his or her human rights, and protection from violence, exploitation and abuse, |
|
| |||||
Birth registration and the right of everyone to recognition everywhere as a person before the law (2013), para. 10 | Feb 25, 2020 | Paragraph | Recognizing also the importance of birth registration, including late birth registration, for the development of vital statistics and the effective implementation of programmes and policies intended to achieve internationally agreed development goals, including the Millennium Development Goals, |
|
|